OBJECTIVE: Hyperglycaemia has been associated with worse outcome following traumatic brain injury and cardiac surgery in adults. We have previously reported no relationship between early postoperative hyperglycaemia and worse neurodevelopmental outcome at 1 year following biventricular repair of congenital heart disease. It is not known if postoperative hyperglycaemia results in worse neurodevelopmental outcome after infant cardiac surgery for single-ventricle lesions. METHODS: Secondary analysis of postoperative glucose levels in infants <6 months of age undergoing Stage I palliation for various forms of single ventricle with arch obstruction. The patients were enrolled in a prospective study of genetic polymorphisms and neurodevelopmental outcomes assessed at 1 year of age with the Bayley Scales of Infant Development-II yielding two indices: mental developmental index (MDI) and psychomotor developmental index (PDI). RESULTS: Stage I palliation was performed on 162 infants with 13 hospital and 15 late deaths (17.3% 1-year mortality). Neurodevelopmental evaluation was performed in 89 of 134 (66.4%) survivors. Glucose levels at admission to the cardiac intensive care unit and during the first 48 postoperative hours were available for 85 of 89 (96%) patients. Mean admission glucose value was 274+/-91 mg dl(-1); the maximum was 291+/-90 mg dl(-1), with 69 of 85 (81%) patients having at least one glucose value >200 mg dl(-1). Only two patients had a value <50 mg dl(-1). Mean MDI and PDI scores were 88+/-16 and 71+/-18, respectively. There were no statistically significant correlations between initial, mean, minimum or maximum glucose measurements and MDI or PDI scores. Only delayed sternal closure resulted in a statistically significant relationship between initial, minimum and maximum glucose values within the context of a multivariate analysis of variance model. CONCLUSIONS: Hyperglycaemia following Stage I palliation in the neonatal period was not associated with lower MDI or PDI scores at 1 year of age.
OBJECTIVE: Hyperglycaemia has been associated with worse outcome following traumatic brain injury and cardiac surgery in adults. We have previously reported no relationship between early postoperative hyperglycaemia and worse neurodevelopmental outcome at 1 year following biventricular repair of congenital heart disease. It is not known if postoperative hyperglycaemia results in worse neurodevelopmental outcome after infant cardiac surgery for single-ventricle lesions. METHODS: Secondary analysis of postoperative glucose levels in infants <6 months of age undergoing Stage I palliation for various forms of single ventricle with arch obstruction. The patients were enrolled in a prospective study of genetic polymorphisms and neurodevelopmental outcomes assessed at 1 year of age with the Bayley Scales of Infant Development-II yielding two indices: mental developmental index (MDI) and psychomotor developmental index (PDI). RESULTS: Stage I palliation was performed on 162 infants with 13 hospital and 15 late deaths (17.3% 1-year mortality). Neurodevelopmental evaluation was performed in 89 of 134 (66.4%) survivors. Glucose levels at admission to the cardiac intensive care unit and during the first 48 postoperative hours were available for 85 of 89 (96%) patients. Mean admission glucose value was 274+/-91 mg dl(-1); the maximum was 291+/-90 mg dl(-1), with 69 of 85 (81%) patients having at least one glucose value >200 mg dl(-1). Only two patients had a value <50 mg dl(-1). Mean MDI and PDI scores were 88+/-16 and 71+/-18, respectively. There were no statistically significant correlations between initial, mean, minimum or maximum glucose measurements and MDI or PDI scores. Only delayed sternal closure resulted in a statistically significant relationship between initial, minimum and maximum glucose values within the context of a multivariate analysis of variance model. CONCLUSIONS: Hyperglycaemia following Stage I palliation in the neonatal period was not associated with lower MDI or PDI scores at 1 year of age.
Authors: Catherine L Dent; James P Spaeth; Blaise V Jones; Steven M Schwartz; Tracy A Glauser; Barbara Hallinan; Jeffrey M Pearl; Philip R Khoury; C Dean Kurth Journal: J Thorac Cardiovasc Surg Date: 2006-01 Impact factor: 5.209
Authors: J William Gaynor; Gail P Jarvik; Judy Bernbaum; Marsha Gerdes; Gil Wernovsky; Nancy B Burnham; Jo Ann D'Agostino; Elaine Zackai; Donna M McDonald-McGinn; Susan C Nicolson; Thomas L Spray; Robert R Clancy Journal: J Thorac Cardiovasc Surg Date: 2005-12-09 Impact factor: 5.209
Authors: Andrew R Yates; Peter C Dyke; Roozbeh Taeed; Timothy M Hoffman; John Hayes; Timothy F Feltes; Clifford L Cua Journal: Pediatr Crit Care Med Date: 2006-07 Impact factor: 3.624
Authors: George M Hoffman; Kathleen A Mussatto; Cheryl L Brosig; Nancy S Ghanayem; Ndidiamaka Musa; Raymond T Fedderly; Robert D B Jaquiss; James S Tweddell Journal: J Thorac Cardiovasc Surg Date: 2005-10 Impact factor: 5.209
Authors: Alexandre Ouattara; Patrick Lecomte; Yannick Le Manach; Marc Landi; Sophie Jacqueminet; Igor Platonov; Nicolas Bonnet; Bruno Riou; Pierre Coriat Journal: Anesthesiology Date: 2005-10 Impact factor: 7.892
Authors: Amanda J Shillingford; Richard F Ittenbach; Bradley S Marino; Jack Rychik; Robert R Clancy; Thomas L Spray; J William Gaynor; Gil Wernovsky Journal: Cardiol Young Date: 2007-03-05 Impact factor: 1.093
Authors: Jean A Ballweg; Gil Wernovsky; Richard F Ittenbach; Judy Bernbaum; Marsha Gerdes; Paul R Gallagher; Troy E Dominguez; Elaine Zackai; Robert R Clancy; Susan C Nicolson; Thomas L Spray; J William Gaynor Journal: Ann Thorac Surg Date: 2007-12 Impact factor: 4.330
Authors: Joseph W Rossano; Michael D Taylor; E O'Brian Smith; Charles D Fraser; E Dean McKenzie; Jack F Price; Heather A Dickerson; David P Nelson; Antonio R Mott Journal: J Thorac Cardiovasc Surg Date: 2008-04 Impact factor: 5.209
Authors: Sarah Tabbutt; Alex S Nord; Gail P Jarvik; Judy Bernbaum; Gil Wernovsky; Marsha Gerdes; Elaine Zackai; Robert R Clancy; Susan C Nicolson; Thomas L Spray; J William Gaynor Journal: Pediatrics Date: 2008-03 Impact factor: 7.124